Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123119824 | 12311982 | 4 | F | 201602 | 20160727 | 20160427 | 20160729 | EXP | BR-ABBVIE-16P-020-1615018-00 | ABBVIE | 91.29 | YR | M | Y | 60.00000 | KG | 20160729 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123119824 | 12311982 | 1 | PS | DEPAKENE | VALPROIC ACID | 1 | Oral | DAILY DOSE: 500MG; IN THE MORNING, AT NIGHT | UNKNOWN | 18081 | 250 | MG | BID | ||||||
| 123119824 | 12311982 | 2 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | FASTING | 0 | QD | |||||||||
| 123119824 | 12311982 | 3 | C | SOTALOL HYDROCHLORIDE. | SOTALOL HYDROCHLORIDE | 1 | Oral | 0.5 TAB DAILY IN THE AFTERNOON | 0 | .5 | DF | QD | |||||||
| 123119824 | 12311982 | 4 | C | BICALUTAMIDE. | BICALUTAMIDE | 1 | Oral | 1 TAB DAILY IN THE AFTERNOON | 0 | 1 | DF | QD | |||||||
| 123119824 | 12311982 | 5 | C | ZILEDON | DONEPEZIL HYDROCHLORIDE | 1 | Oral | 10MG DAILY AT NIGHT | 0 | 10 | MG | QD | |||||||
| 123119824 | 12311982 | 6 | C | VITERSOL D | CHOLECALCIFEROL | 1 | Oral | 1 CAPSULE DAILY AFTER LUNCH | 0 | 1 | DF | QD | |||||||
| 123119824 | 12311982 | 7 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 1 TAB DAILY AT NIGHT | 0 | 1 | DF | QD | |||||||
| 123119824 | 12311982 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 0.5 TAB DAILY AT NIGHT; FREQUENCY:ALTERNATE-PATIENT TAKES 1 DAY AND THEN STOPS FOR 2 DAYS | 0 | .5 | DF | ||||||||
| 123119824 | 12311982 | 9 | C | PURAN | LEVOTHYROXINE SODIUM | 1 | Oral | 25MG DAILY; FASTING | 0 | 25 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123119824 | 12311982 | 1 | Convulsion prophylaxis |
| 123119824 | 12311982 | 2 | Prophylaxis |
| 123119824 | 12311982 | 3 | Arrhythmia |
| 123119824 | 12311982 | 4 | Prostate cancer |
| 123119824 | 12311982 | 5 | Memory impairment |
| 123119824 | 12311982 | 6 | Vitamin supplementation |
| 123119824 | 12311982 | 7 | Blood triglycerides |
| 123119824 | 12311982 | 8 | Diuretic therapy |
| 123119824 | 12311982 | 9 | Hypothyroidism |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123119824 | 12311982 | OT |
| 123119824 | 12311982 | DS |
| 123119824 | 12311982 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123119824 | 12311982 | Death | |
| 123119824 | 12311982 | Dysphagia | |
| 123119824 | 12311982 | Gait disturbance | |
| 123119824 | 12311982 | Illusion | |
| 123119824 | 12311982 | Neoplasm | |
| 123119824 | 12311982 | Pneumonia | |
| 123119824 | 12311982 | Skin cancer metastatic |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123119824 | 12311982 | 1 | 2013 | 0 | ||
| 123119824 | 12311982 | 3 | 2013 | 0 | ||
| 123119824 | 12311982 | 4 | 2004 | 0 | ||
| 123119824 | 12311982 | 5 | 201508 | 0 | ||
| 123119824 | 12311982 | 6 | 201512 | 0 | ||
| 123119824 | 12311982 | 8 | 2010 | 0 | ||
| 123119824 | 12311982 | 9 | 2010 | 0 |